Risk Factors, Costs, and Impacts of ED Boarding
NCT07532564
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsNCT Number: NCT01818635
The purpose of the study to investigate whether montelukast lead to behavior problems in children with asthma.
Looking for future studies?
Notify Me18 month–60 month
All sexes
Observational
Fatih University, Ankara, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8 months
Montelukast frequently used in the treatment of asthmatic children. However, we believe that montelukast lead to behavior problems. In this study, we aimed to investigate that intake of montelukast whether lead to behavior problems.
Time frame: 8 months
In this study, it will be compared the effect on behavior changes between intake of inhaled steroid and montelukast.
Fatih University
Other
Phase 4 Study of to Investigation the Effect of Montelukast on Behavior Problems in Children With Asthma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07532564
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsNCT03269110
Asthma, Autism Spectrum Disorder
Penrith, New South Wales, Australia
View Trial DetailsNCT03106727
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Neno, Malawi
View Trial DetailsNCT03330301
Arthritis, Asthma
Frederiksberg, Denmark
View Trial Details